News

The path to market for Roche’s astegolimab became more uncertain after the investigational antibody failed to significantly ...
Astegolimab from Roche's Genentech fails phase 3 COPD trial, reflecting challenges in monoclonal antibody treatment for the ...
The fate of IL-33-targeting astegolimab will be determined by talks with regulators, after Roche AG’s Genentech unit rolled out mixed results from a pair of studies testing the compound vs. placebo on ...
"While COPD remains the third leading cause of death worldwide, patients and families have limited treatment options for ...
Roche Holding said its astegolimab drug candidate achieved mixed results in two clinical trials for chronic obstructive pulmonary disease, missing the main goal in a late-stage study. The Swiss ...
Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...
India is home to over 267 million tobacco users, struggling with a public health crisis rooted in mass consumption and ...
Ingvar Ambjørnsen, a Norwegian author who mixed a sharp, even dark tone with humor and empathy in works that depicted the ...